Congo, Democratic Republic of the vs Low income (World Bank): Treatment success rate: XDR-TB cases
Congo, Democratic Republic of the
100
in 2022
Low income (World Bank)
70
in 2022
Congo, Democratic Republic of the rank
1st
Low income (World Bank) rank
4th
Treatment success rate: XDR-TB cases over time
- Congo, Democratic Republic of the
- Low income (World Bank)
How they compare
Congo, Democratic Republic of the currently reports 100 against 70 in Low income (World Bank), a difference of 30.
That makes Congo, Democratic Republic of the's figure about 1.4 times Low income (World Bank)'s.
The two have swapped places 3 times across 8 shared years of data; in 2015 it was Low income (World Bank) ahead.
Congo, Democratic Republic of the ranks 1st and Low income (World Bank) ranks 4th of 82 countries.
Congo, Democratic Republic of the has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Low income (World Bank) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 54.6 | 53.6 | 1 | Congo, Democratic Republic of the |
| 2020s | 90.33 | 71 | 19.33 | Congo, Democratic Republic of the |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Congo, Democratic Republic of the or Low income (World Bank)?
- Congo, Democratic Republic of the, at 100 against 70 in Low income (World Bank) as of 2022.
- What is the difference in treatment success rate: xdr-tb cases between Congo, Democratic Republic of the and Low income (World Bank)?
- 30, with Congo, Democratic Republic of the ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Low income (World Bank)?
- 8 years are reported by both, from 2015 to 2022.
- How do Congo, Democratic Republic of the and Low income (World Bank) rank globally for treatment success rate: xdr-tb cases?
- Congo, Democratic Republic of the ranks 1st and Low income (World Bank) ranks 4th of 82 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.